A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

  • Kao, C; McNamara, M; Alley, C; Spector, N; Jauhari, S; Gupta, RT; Zhang, T; Zhu, J

Published Date

  • June 2019

Published In

Volume / Issue

  • 17 / 3

Start / End Page

  • e672 - e677

PubMed ID

  • 31097390

Electronic International Standard Serial Number (EISSN)

  • 1938-0682

Digital Object Identifier (DOI)

  • 10.1016/j.clgc.2019.03.019


  • eng

Conference Location

  • United States